Christopher Duncombe

Statistics

Publications

Citations

H-Index

Active since

1997

Affiliations

National Centre for Clinical Research on Emerging Drugs(Current)

Christopher Duncombe is an author at National Centre for Clinical Research on Emerging Drugs specializing in infectious diseases, open-label trials, and pharmacy.

Publications per year

1997–2006

Publications

Safety and Immunogenicity of UBI HIV-1 <sub>MN</sub> Octameric V3 Peptide Vaccine Administered by Subcutaneous Injection

Anthony D. Kelleher, Sean Emery, Philip Cunningham et al. · AIDS Research and Human Retroviruses · 1997 · 29 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Boosted versus Unboosted Indinavir with Zidovudine and Lamivudine in Nucleoside Pre-Treated Patients: A Randomized, Open-Label Trial with 112 Weeks of Follow-Up (HIV-Nat 005)

Mark Boyd, Preeyaporn Srasuebkul, Mana Khongphattanayothin et al. · Antiviral Therapy · 2006 · 20 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Greater Reversal of CD4 <sup>+</sup> Cell Abnormalities and Viral Load Reduction after Initiation of Antiretroviral Therapy with Zidovudine, Lamivudine, and Nelfinavir before Complete HIV Type 1 Seroconversion

Don Smith, Gilbert R. Kaufmann, James O. Kahn et al. · AIDS Research and Human Retroviruses · 2003 · 12 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

1–3 of 3